🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and assertions of next-day British shipping. Sellers promote the drug there before directing buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Several professionals stated the popularity for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.

Platform Response and Content Removal

According to TikTok, the service has taken down violative content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, filled with photos of slimming results, positive reviews and detailed guides for preparing or administering at home.

After minutes of entering one group, a vendor shared contact information, where most purchases occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, medical conditions or past usage.

Product Details and Costs

Inside these groups, posts show dark colored parcels with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram said it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Although the science behind this drug is sound, these online versions may not include what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to potentially serious health risks”.